Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

343 ARTÍCULOS , VIENDO DEL 331 AL 343

The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review

Awan KH.

Saudi Pharm J. 2017 Jan;25(1):18-24. doi: 10.1016/j.jsps.2016.04.024. Epub 2016 Apr 30.

Focal cervical dystonia presents in the setting of acute cerebellar hemorrhage

Wagle Shukla A, De Jesus S, Meng FG, Hu W.

J Neurol Sci. 2017 Apr 15;375:307-308. doi: 10.1016/j.jns.2016.12.037. Epub 2016 Dec 22.

[Tardive movement disorders with antipsychotics – a case of aripirazole-induced tardive dystonia and review of the literature]

Pitzer M, Engelmann G, Stammschulte T.

Z Kinder Jugendpsychiatr Psychother. 2017 Jul;45(4):325-334. doi: 10.1024/1422-4917/a000460. Epub 2016 Sep 26.

Bruxism in Movement Disorders: A Comprehensive Review

Ella B, Ghorayeb I, Burbaud P, Guehl D.

J Prosthodont. 2017 Oct;26(7):599-605. doi: 10.1111/jopr.12479. Epub 2016 Apr 14.

Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?

Malek N, Newman EJ.

Acta Neurol Scand. 2017 Jan;135(1):25-33. doi: 10.1111/ane.12609. Epub 2016 May 6.

Memantine-induced chorea and dystonia

Borges LG, Bonakdarpour B.

Pract Neurol. 2017 Apr;17(2):133-134. doi: 10.1136/practneurol-2016-001470. Epub 2016 Dec 7.

A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder

Garone C, Gurgel-Giannetti J, Sanna-Cherchi S, Krishna S, Naini A, Quinzii CM, Hirano M.

J Child Neurol. 2017 Feb;32(2):246-250. doi: 10.1177/0883073816666221. Epub 2016 Sep 28.

Mosaicism in ATP1A3-related disorders: not just a theoretical risk

Hully M, Ropars J, Hubert L, Boddaert N, Rio M, Bernardelli M, Desguerre I, Cormier-Daire V, Munnich A, de Lonlay P, Reilly L, Besmond C, Bahi-Buisson N.

Neurogenetics. 2017 Jan;18(1):23-28. doi: 10.1007/s10048-016-0498-9. Epub 2016 Oct 10.

Baclofen Toxicity in a Patient with Hemodialysis-Dependent End-Stage Renal Disease

Porter LM, Merrick SS, Katz KD.

J Emerg Med. 2017 Apr;52(4):e99-e100. doi: 10.1016/j.jemermed.2016.09.025. Epub 2016 Oct 24.

Pyruvate dehydrogenase-E1α deficiency presenting as recurrent acute proximal muscle weakness of upper and lower extremities in an 8-year-old boy

Kara B, Genç HM, Uyur-Yalçın E, Sakarya-Güneş A, Topçu U, Mülayim S, Ceylaner S.

Neuromuscul Disord. 2017 Jan;27(1):94-97. doi: 10.1016/j.nmd.2016.11.001. Epub 2016 Nov 9.

New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients

Vroegindeweij LHP, Langendonk JG, Langeveld M, Hoogendoorn M, Kievit AJA, Di Raimondo D, Wilson JHP, Boon AJW.

Parkinsonism Relat Disord. 2017 Mar;36:33-40. doi: 10.1016/j.parkreldis.2016.12.010. Epub 2016 Dec 15.

Early-Onset Parkinsonism: Case Report and Review of the Literature

Al-Rumayyan A, Klein C, Alfadhel M.

Pediatr Neurol. 2017 Feb;67:102-106.e1. doi: 10.1016/j.pediatrneurol.2015.06.005. Epub 2015 Oct 23.

POLR3-Related Leukodystrophy

Bernard G, Vanderver A.

2012 Aug 2 [updated 2017 May 11]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias